Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.
(Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)
Bausch + Lomb to buy dry-eye drug from Novartis for $1.75 billion - WSJ
2023-06-30 19:24
Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis,
You Might Like...
Public Storage to acquire Simply Self Storage for $2.2 billion
Pfizer trims expectations for 2023 with sales of COVID-19 vaccine, treatment, weaker than thought
Philippines posts forecast-beating Q3 growth but risks remain
China's Country Garden suspends trading of onshore bonds amid talk of debt restructuring
Boomi Continues Global Growth In Barcelona, Spain
Versatile and Procore Collaborate to Revolutionize Construction Data Management
Stock market today: Wall Street ends higher; Activision jumps
Bring some happy vibes home with fall's 'dopamine decor' trend